 MELBOURNE, Australia, Nov. 10, 2022 GLOBE NEWSWIRE -- Opthea Limited NASDAQ:OPT; ASX:OPT, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced that Chief Executive Officer Dr. Megan Baldwin will present at the Jefferies London Healthcare Conference on Tuesday, November 15, 2022 at 7:25 AM GMT 6:25 PM AEDT. 